Signet Investment Advisory Group’s AbbVie ABBV Stock Holding History

Signet Investment Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,475	Closed	-$239K	–	77
2022 Q1	$239K	Hold	1,475	–	–	0.14%	77
2021 Q4	$200K	Buy	+1,475	New	+$174K	0.11%	81
2021 Q1	–	Sell	-1,475	Closed	-$158K	–	78
2020 Q4	$158K	Buy	+1,475	New	+$142K	0.12%	77
2019 Q1	–	Sell	-675	Closed	-$62K	–	76
2018 Q4	$62K	Buy	+675	New	+$59.4K	0.07%	92

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Signet Investment Advisory Group's ABBV Position: Q2 2022 in Review

Signet Investment Advisory Group sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 1,475 shares — an estimated $239K sold.

Signet Investment Advisory Group first reported a position in ABBV in Q4 2018 and held it in 4 quarters. The position peaked at $239K in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Signet Investment Advisory Group reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Signet Investment Advisory Group sold 1,475 AbbVie shares in Q2 2022, an estimated $239K.
Signet Investment Advisory Group first reported a position in AbbVie in Q4 2018 and held it in 4 quarters.
Signet Investment Advisory Group's AbbVie position peaked at $239K in Q1 2022.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Signet Investment Advisory Group's 13F filing for Q2 2022, filed 3 Aug 2022.